title: Clinical inquiries. Do COX-2 inhibitors worsen renal function?
authors.affiliation: Department of Family Medicine, Mayo Clinic Arizona, Scottsdale, USA.
authors.forename: Richard
authors.initials: R
authors.lastname: Wall
authors.forename: Carmen
authors.initials: C
authors.lastname: Strickland
authors.forename: Barbara
authors.initials: B
authors.lastname: Jamieson
authors.forename: Vincent
authors.initials: V
authors.lastname: Lo
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000453:epidemiology; D000068579:Celecoxib; D000075202:Contraindications; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D007783:Lactones / Q000009:adverse effects / Q000627:therapeutic use*; D010003:Osteoarthritis / Q000188:drug therapy* / Q000453:epidemiology; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use*; D051437:Renal Insufficiency / Q000453:epidemiology; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*; D013450:Sulfones / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib